Join world’s leading researchers for an in-depth discussion of ethical, clinical, and legal issues related to MDMA-Assisted Therapy, a new form of therapy that combines psychological treatment and a powerful psychoactive MDMA medication. Promising clinical research suggests that this unique therapy might become medically available in Canada and USA for treatment of trauma as early as 2022. Presenters will discuss issues such as safety, training and regulation, equity and access, and broader future healing potential such as relationship healing. The conference will consider MDMA-assisted therapy within the broader context of psychedelic-assisted therapy, and will offer global, cultural, and historical perspectives on the issue.
March 7, 2021
Press Release: Rahn & Associates Launches Risk Management Solutions Specifically for Psychedelic Medicinal Businesses
July 21, 2021